title: Analyzing global trends of biomarker use in drug interventional clinical studies.
abstract: The trend of biomarker use in drug interventional clinical studies was analyzed using ClinicalTrials.gov to provide an overview of how biomarkers are used to streamline clinical studies and to examine regional differences. A total of 3,383 clinical study data was analyzed according to phase, region, sponsor, and therapeutic class. The number of clinical studies using biomarkers has been increasing constantly and is dependent on the number of Phase I and II studies. The majority of studies (58.5%) were sponsored by the United States, with the studies being conducted mainly in the sponsor's home region (80.3%). The use of biomarkers was prominent in the oncology area (37.1%). Although current data indicates some bias in the clinical use of biomarkers, it is expected that their use will increase in later phase studies or other therapeutic areas as biomarker development proceeds. In addition, limited regional use of biomarkers may lead to differences in biomarker use in drug development and in combination with political support may result in differences in competitiveness of drug development. Biomarkers would be a powerful tool against deteriorating research and development productivity when used more in appropriate clinical study conditions.
authors.affiliation: Graduate School of Pharmaceutical Science, The University of Tokyo, Tokyo, Japan. hayashi-opir@jpma.or.jp
authors.forename: K
authors.initials: K
authors.lastname: Hayashi
authors.forename: S
authors.initials: S
authors.lastname: Masuda
authors.forename: H
authors.initials: H
authors.lastname: Kimura
mesh_terms: D054316:Biomarkers, Pharmacological; D002986:Clinical Trials as Topic / Q000379:methods* / Q000706:statistics & numerical data / Q000639:trends*; D055808:Drug Discovery / Q000639:trends*; D005062:European Union / Q000706:statistics & numerical data; D006801:Humans; D007564:Japan; D012042:Registries; D014481:United States
chemical_list: D054316:Biomarkers, Pharmacological